OncoC4, Inc.
PrivateLast Round
Series B
Oct 2, 2025
Est. Valuation
$660M
Total Funding Raised
$250M
Company Overview
OncoC4, Inc. is a clinical-stage biotechnology company that discovers and develops novel biologics for the treatment of cancer and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoC4, Inc. Comps
Public and private peers based on sector, stage, and business model.
OncoC4, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 2, 2025 | ||||
| Strategic | Mar 20, 2023 |
Key People
Founding team and executive leadership
OncoC4, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bencao Capital | Series B |
| Kaitai Capital | Series B |
| Greater Bay Area Homeland | Series B |
| HM Venture Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 191% MoM, reaching 7.4K.
- Nov 11, 2025
Monthly visitors grew 158% MoM, reaching 3.6K.
OncoC4, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoC4, Inc.'s valuation, stock price, and market status.
